Immuno-Metabolic Modulation of Liver Oncogenesis by the Tryptophan Metabolism - Archive ouverte HAL Access content directly
Journal Articles Cells Year : 2021

Immuno-Metabolic Modulation of Liver Oncogenesis by the Tryptophan Metabolism

(1) , (1) , (1)
1

Abstract

Metabolic rewiring in tumor cells is a major hallmark of oncogenesis. Some of the oncometabolites drive suppressive and tolerogenic signals from the immune system, which becomes complicit to the advent and the survival of neoplasia. Tryptophan (TRP) catabolism through the kynurenine (KYN) pathway was reported to play immunosuppressive actions across many types of cancer. Extensive debate of whether the culprit of immunosuppression was the depletion of TRP or rather KYN accumulation in the tumor microenvironment has been ongoing for years. Results from clinical trials assessing the benefit of inhibiting key limiting enzymes of this pathway such as indoleamine 2,3-dioxygenase (IDO1) or tryptophan 2,3-dioxygenase (TDO2) failed to meet the expectations. Bearing in mind the complexity of the tumoral terrain and the existence of different cancers with IDO1/TDO2 expressing and non-expressing tumoral cells, here we present a comprehensive analysis of the TRP global metabolic hub and the driving potential of the process of oncogenesis with the main focus on liver cancers.
Fichier principal
Vignette du fichier
cells-10-03469.pdf (2.79 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

inserm-03920731 , version 1 (03-01-2023)

Identifiers

Cite

Véronique Trézéguet, Hala Fatrouni, Aksam Merched. Immuno-Metabolic Modulation of Liver Oncogenesis by the Tryptophan Metabolism. Cells, 2021, 10 (12), pp.3469. ⟨10.3390/cells10123469⟩. ⟨inserm-03920731⟩

Collections

INSERM
0 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More